HK1205456A1 - 包含替格瑞洛的固態口服醫藥製劑 - Google Patents

包含替格瑞洛的固態口服醫藥製劑

Info

Publication number
HK1205456A1
HK1205456A1 HK15106027.7A HK15106027A HK1205456A1 HK 1205456 A1 HK1205456 A1 HK 1205456A1 HK 15106027 A HK15106027 A HK 15106027A HK 1205456 A1 HK1205456 A1 HK 1205456A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulation
formulation containing
solid oral
oral pharmaceutical
containing ticagrelor
Prior art date
Application number
HK15106027.7A
Other languages
English (en)
Inventor
格雷戈爾‧塞德馬克
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of HK1205456A1 publication Critical patent/HK1205456A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
HK15106027.7A 2012-10-16 2015-06-24 包含替格瑞洛的固態口服醫藥製劑 HK1205456A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2012-705A CZ2012705A3 (cs) 2012-10-16 2012-10-16 Pevná orální farmaceutická formulace obsahující ticagrelor
PCT/CZ2013/000130 WO2014059955A1 (en) 2012-10-16 2013-10-15 A solid oral pharmaceutical formulation containing ticagrelor

Publications (1)

Publication Number Publication Date
HK1205456A1 true HK1205456A1 (zh) 2015-12-18

Family

ID=49619770

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106027.7A HK1205456A1 (zh) 2012-10-16 2015-06-24 包含替格瑞洛的固態口服醫藥製劑

Country Status (13)

Country Link
EP (1) EP2908802A1 (zh)
JP (1) JP6301934B2 (zh)
KR (1) KR20150067153A (zh)
CN (1) CN104661649A (zh)
BR (1) BR112015008076A2 (zh)
CZ (1) CZ2012705A3 (zh)
EA (1) EA201590745A1 (zh)
HK (1) HK1205456A1 (zh)
IL (1) IL238036B (zh)
MX (1) MX2015003866A (zh)
UA (1) UA116784C2 (zh)
WO (1) WO2014059955A1 (zh)
ZA (1) ZA201501954B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160012706A (ko) * 2014-07-25 2016-02-03 동아에스티 주식회사 서방성 제제
CN111544407A (zh) * 2015-04-29 2020-08-18 江苏恒瑞医药股份有限公司 一种替格瑞洛或其可药用盐的制剂
CN105193759B (zh) * 2015-09-18 2018-07-03 乐普药业股份有限公司 一种替格瑞洛片及其制备方法
CN106667926B (zh) * 2015-11-09 2020-01-17 石药集团中奇制药技术（石家庄）有限公司 一种法匹拉韦片剂及其制备方法
TR201601835A2 (tr) * 2016-02-12 2017-08-21 Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇kagrelor i̇çeren formülasyonlar i̇çi̇n üreti̇m yöntemi̇
CN107595789B (zh) * 2016-04-21 2021-01-15 阿斯利康(瑞典)有限公司 口腔崩解片
TR201617983A2 (tr) * 2016-12-07 2018-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇cagrelorun kati oral farmasöti̇k bi̇leşi̇mleri̇
KR102610876B1 (ko) * 2018-03-05 2023-12-06 주식회사 파마코스텍 티카그렐러 푸마르산 i형 결정 및 그 제조방법
WO2019170244A1 (en) 2018-03-08 2019-09-12 Pharmaceutical Oriented Services Ltd. Ticagrelor—containing tablet formulation
EP3829547A1 (en) 2018-07-27 2021-06-09 KRKA, d.d., Novo mesto Pharmaceutical composition of ticagrelor
CN111450067A (zh) * 2019-01-18 2020-07-28 北京万全德众医药生物技术有限公司 一种替格瑞洛分散片及其制备方法
CN116370423A (zh) * 2023-02-28 2023-07-04 天津力生制药股份有限公司 一种替格瑞洛口腔崩解片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
JPH11199517A (ja) * 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
WO2007018057A1 (ja) * 2005-08-05 2007-02-15 Freund Corporation 口腔内速崩壊錠およびその製造法
WO2008024044A1 (en) * 2006-08-21 2008-02-28 Astrazeneca Ab Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate
TWI482772B (zh) 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
WO2011067571A1 (en) 2009-12-03 2011-06-09 Astrazeneca Ab Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
ES2550033T3 (es) * 2009-12-23 2015-11-04 Ratiopharm Gmbh Forma de dosificación farmacéutica sólida de ticagrelor

Also Published As

Publication number Publication date
ZA201501954B (en) 2017-04-26
MX2015003866A (es) 2015-07-17
CZ2012705A3 (cs) 2014-04-23
UA116784C2 (uk) 2018-05-10
IL238036A0 (en) 2015-05-31
JP2015533129A (ja) 2015-11-19
CN104661649A (zh) 2015-05-27
WO2014059955A1 (en) 2014-04-24
EP2908802A1 (en) 2015-08-26
BR112015008076A2 (pt) 2017-07-04
KR20150067153A (ko) 2015-06-17
EA201590745A1 (ru) 2015-08-31
IL238036B (en) 2019-05-30
JP6301934B2 (ja) 2018-03-28

Similar Documents

Publication Publication Date Title
HK1211209A1 (zh) 含噻吩幷-三唑幷二氮雜化合物的藥物配方
HK1205456A1 (zh) 包含替格瑞洛的固態口服醫藥製劑
EP2906202A4 (en) DRUG FORMULATIONS FOR ORAL ADMINISTRATION
HRP20181193T1 (hr) Farmaceutska kompozicija koja se može oralno administrirati
HK1199821A1 (zh) 口服用醫藥組合物
GB2486567B (en) Pharmaceutical formulation
HK1205146A1 (zh) 藥物製劑
ZA201501897B (en) A pharmaceutical composition
LT3473255T (lt) Farmacinė vaisto forma, apimanti ciklezonidą
HK1207290A1 (zh) 口服製劑
LT2895171T (lt) Stabili farmacinė kompozicija, turinti vardenafilo hidrochlorido
RS59631B1 (sr) Farmaceutska formulacija koja sadrži kurkumin
HK1204945A1 (zh) 含有氟吡汀的藥物製劑
HK1209339A1 (zh) 藥物配方
GB201211403D0 (en) Pharmaceutical formulations
GB201211406D0 (en) Pharmaceutical formulations
GB201221367D0 (en) A pharmaceutical composition